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It has come to our attention that an error was made in the final assembly of Figures 7A and 7B. While the figure legends and data
labels for the two graphs were correct, the graphs themselves were transposed. We have now corrected this error in the revised
Figures 7A and 7B, printed below. This oversight has no bearing on the conclusions reached in this study and we apologize for
any confusion caused by the transposed graphs.Figure 7. Effects of 968 on B Lymphoma
Cells and Cdc42(F28L)-Transformed Cells
Overexpressing GAC
(A) P493 B lymphoma cells were cultured in RPMI
1640 medium supplemented with 10% fetal
bovine serum in the presence of the indicated
concentrations of 968.
(B) P493 B lymphoma cells were cultured in RPMI
1640 medium supplemented with 10% fetal
bovine serum in the presence of the inactive
968-analog 335.
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